Alzheimer; News from the web:
AstraZeneca plc (AZN – Analyst Report) and Eli Lilly and Company (LLY – Analyst Report) announced that a phase II/III study (AMARANTH) on their BACE inhibitor, AZD3293, will continue into phase III of the phase II/III seamless study. AZD3293 is being evaluated for the treatment of patients suffering from early Alzheimer’s disease – the most common form of dementia.
Read all about it HERE
Alzheimer; News from the web:
Alzheimer’s disease impairs insulin signalling in the brain, making a person with the most common form of dementia more likely to develop diabetes, suggests a new research conducted in mice.
Read all about it HERE
Alzheimer; News from the web:
Read the article in the link for today to learn about the bureaucratic challenges to get the life saving drugs, even when approved, to all that will need it.
Read all about it HERE
Alzheimer; News from the web:
That is not a new character in a new Star Wars movie but rather the name of a newly developed, or should I say in development, drug. The researchers however cannot find funding so they turned to crowdfunding the project.
Read all about it HERE
Alzheimer; News from the web:
This quote sounds very promising:
“This study is a major advance in our understanding of the molecular mechanisms underlying Alzheimer’s, in demonstrating a causal role for immune molecules in this disease,”
Read all about it HERE
Alzheimer; News from the web:
A team of researchers systematically assessed the association between oral health and cognitive function in adult populations, and found that there is an association between tooth loss and reduced cognitive function.
Read all about it HERE